Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is designted to know optimal dose of Ramosteron to control for chemotherapy
induced nasea and vomoting (CINV)based on its pharmacokinetics, pharmacodynamic study and
clinilcal parameters using Rhodes Index.